Probiotics and inflammatory bowel disease

被引:45
作者
Jonkers, D [1 ]
Stockbrügger, R [1 ]
机构
[1] Univ Hosp Maastricht, Dept Gastroenterol & Hepatol, POB 5800, NL-6202 AZ Maastricht, Netherlands
关键词
D O I
10.1177/014107680309600403
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:167 / 171
页数:5
相关论文
共 48 条
[11]  
Havenaar R., 1992, Probiotics: the scientific basis., P209
[12]   Overview of gut flora and probiotics [J].
Holzapfel, WH ;
Haberer, P ;
Snel, J ;
Schillinger, U ;
Huis in't Veld, JHJ .
INTERNATIONAL JOURNAL OF FOOD MICROBIOLOGY, 1998, 41 (02) :85-101
[13]   The role of the fecal stream in Crohn's disease: An historical and analytical review [J].
Janowitz, HD ;
Croen, EC ;
Sachar, DB .
INFLAMMATORY BOWEL DISEASES, 1998, 4 (01) :29-39
[14]  
Kennedy RJ, 2000, SCAND J GASTROENTERO, V35, P1266, DOI 10.1080/003655200453601
[15]  
Kordecki HJ, 2001, GUT, V49, P2880
[16]   Double-blind comparison of an oral Escherichia coli preparation and mesalazine in maintaining remission of ulcerative colitis [J].
Kruis, W ;
Schutz, E ;
Fric, P ;
Fixa, B ;
Judmaier, G ;
Stolte, M .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1997, 11 (05) :853-858
[17]   Maintenance of remission in ulcerative colitis is equally effective with Escherichia coli Nissle 1917 and with standard mesalamine [J].
Kruis, W ;
Fric, P ;
Stolte, MS .
GASTROENTEROLOGY, 2001, 120 (05) :A127-A127
[18]   The bacterial flora in inflammatory bowel disease: Current insights in pathogenesis and the influence of antibiotics and probiotics [J].
Linskens, RK ;
Huijsdens, XW ;
Savelkoul, PHM ;
Vandenbroucke-Grauls, CMJE ;
Meuwissen, SGM .
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2001, 36 :29-40
[19]   FECAL BACTERIOLOGY AND RESERVOIR ILEITIS IN PATIENTS OPERATED ON FOR ULCERATIVE-COLITIS [J].
LUUKKONEN, P ;
VALTONEN, V ;
SIVONEN, A ;
SIPPONEN, P ;
JARVINEN, H .
DISEASES OF THE COLON & RECTUM, 1988, 31 (11) :864-867
[20]  
MacDonald TT, 2000, SCAND J IMMUNOL, V51, P2